We are live on ! Find out more

CollPlant Biotechnologies

CLGN

Market cap $14.3M

1 day

5 days

1 month

3 months

6 months

Year to date

1 year

5 years

10 years

About: CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Employees: 39

Healthcare Biotechnology

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

CollPlant to Begin Trading on Nasdaq Under New Ticker Symbol “OPHI”

OPHI marks another important step in CollPlant's strategy to expand and focus its operations built around LightSolver's all-optical Laser Processing Unit (LPU)™ OPHI marks another important step in CollPlant's strategy to expand and focus its operations built around LightSolver's all-optical Laser Processing Unit (LPU)™

CollPlant to Begin Trading on Nasdaq Under New Ticker Symbol “OPHI”

LightSolver to Unveil the First Public Demonstration of its All-Optical Computer at SC26

Rehovot, Israel, Nov. 11, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd.

LightSolver to Unveil the First Public Demonstration of its All-Optical Computer at SC26

LightSolver Secures ~$1.8 Million Grant from Israel's Innovation Authority to Advance its Laser Processing Unit (LPU)

Government-backed R&D program to advance next-generation LPU hardware and expand the LPU Lab platform Builds on LightSolver's recent commercial and technical momentum, including the strategic partnership with Boeing, peer-reviewed research with HLRS and a growing IP portfolio

LightSolver Secures ~$1.8 Million Grant from Israel's Innovation Authority to Advance its Laser Processing Unit (LPU)

CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light

Rehovot, Israel, Nov. 04, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its Board of Directors has approved a proposal to change the Company's name to OptiPhi Computing Ltd.

CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light

LightSolver Secures Paid Collaboration with the Israel Ministry of Defense for the Development of Photonic Computing Technology

Rehovot, Israel, Oct. 29, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd.

LightSolver Secures Paid Collaboration with the Israel Ministry of Defense for the Development of Photonic Computing Technology

COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT

Transaction Led Primarily by Existing Investors to Accelerate LightSolver's Laser-Based Supercomputing Development REHOVOT, Israel, Oct. 9, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), an innovative technology company operating at the intersection of deep-tech photonic computing and biotechnology today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 989,301 of the Company's ordinary shares (or ordinary share equivalents in lieu thereof) and unregistered warrants to purchase up to 1,483,952 ordinary shares in a private placement at a combined purchase price of $3.74 per ordinary share and accompanying warrants (or $3.7399 per ordinary share equivalent and accompanying warrants). The private placement, which is comprised primarily of the Company's existing investors, reflects confidence in CollPlant's expanded strategic vision and its execution capabilities in deep-tech photonic computing.

COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT

LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations

CollPlant Advances its Photonic Computing Strategy Through LightSolver's Growing IP Portfolio REHOVOT, Israel, Oct. 6, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary, LightSolver, has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for an invention that significantly expands the capabilities of its all-optical, laser-based computing platform.

LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations

COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Strategic Expansion into Photonic Computing via LightSolver Acquisition Diversifies Technology Portfolio Alongside Continued Innovations in Regenerative Medicine REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), today announced financial results for the second quarter of 2026 and provided a corporate update.

COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads

Peer-reviewed study published by ACM: LightSolver's LPU architecture demonstrated significantly lower projected time-to-solution, compared to state-of-the-art algorithms running on a GPU REHOVOT, Israel, September 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced the publication of joint research conducted by its subsidiary LightSolver Ltd.

LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads

CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nasdaq confirms the Company satisfies continued listing criteria under Listing Rule 5550(a)(2), officially closing the compliance matter Follows the recent completion of the LightSolver acquisition, marking CollPlant's strategic expansion into high-performance computing (HPC) and photonics REHOVOT, Israel, Sept. 22, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd.

CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement

See News Rankings

Price charts implemented using Lightweight Charts™